Anar al contingut
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Correction: Molecular profile...
  • Citar
  • Enviar aquest missatge de text
  • Enviar per correu electrònic aquest
  • Imprimir
  • Exportar registre
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Enllaç permanent
Correction: Molecular profile of BRCA-mutated biliary tract cancers

Correction: Molecular profile of BRCA-mutated biliary tract cancers

Dades bibliogràfiques
Autors principals: Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Format: Article
Idioma:English
Publicat: Elsevier 2020-10-01
Col·lecció:ESMO Open
Accés en línia:https://esmoopen.bmj.com/content/5/5/e000682corr1.full
  • Fons
  • Descripció
  • Ítems similars
  • Visualització del personal

Internet

https://esmoopen.bmj.com/content/5/5/e000682corr1.full

Ítems similars

  • SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
    per: Matthias Preusser, et al.
    Publicat: (2020-10-01)
  • Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
    per: Angelika M. Starzer, et al.
    Publicat: (2022-04-01)
  • Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
    per: Maximilian J. Mair, et al.
    Publicat: (2023-02-01)
  • DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
    per: Matthias Preusser, et al.
    Publicat: (2022-03-01)
  • New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
    per: Anna S. Berghoff, et al.
    Publicat: (2019-06-01)

Opcions de cerca

  • Historial de cerca
  • Cerca avançada

Trobar-ne més

  • Explorar el catàleg
  • Explorar alfabèticament
  • Explora canals
  • Bibliografia recomanada
  • Nous ítems

Necessites ajuda?

  • Consells de cerca
  • Pregunteu al bibliotecari
  • FAQs